story of the week
Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy (FF/UMEC/VI) vs FF/VI in Patients With Inadequately Controlled Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI in Patients With Inadequately Controlled Asthma (CAPTAIN): A Double-Blind, Randomised, Phase 3A Trial
Lancet Respir Med 2020 Sep 09;[EPub Ahead of Print], LA Lee, Z Bailes, N Barnes, LP Boulet, D Edwards, A Fowler, NA Hanania, HAM Kerstjens, E Kerwin, R Nathan, J Oppenheimer, A Papi, S Pascoe, G Brusselle, G Peachey, N Sule, M Tabberer, ID PavordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.